TP53 and cancer: The targeted and sustained/controlled co-delivery of anticancer drugs and the TP53 gene to cancer cells leads to the repression of their growth and expansion, circumventing secondary effects due to the application of lower drug doses, constituting a reliable approach to fight cancer.